AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitorFeng Ren, Alex Zhavoronkov, Shanshan Kong et al.|Chemical Science|2023Cited by 322
PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker DiscoveryPetrina Kamya, Alex Zhavoronkov, Ivan V. Ozerov et al.|Journal of Chemical Information and Modeling|2024Cited by 125
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery PlatformFrank W. Pun, Alex Zhavoronkov, Bonnie Hei Man Liu et al.|Frontiers in Aging Neuroscience|2022Cited by 99
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engineFrank W. Pun, Alex Zhavoronkov, Geoffrey Ho Duen Leung et al.|Aging|2022Cited by 82
A comprehensive <scp>AI</scp>‐driven analysis of large‐scale omic datasets reveals novel dual‐purpose targets for the treatment of cancer and agingFrank W. Pun, Alex Zhavoronkov, Geoffrey Ho Duen Leung et al.|Aging Cell|2023Cited by 40